Democratizing data-driven cell and gene therapy, together.

At Divergene, our mission revolves around shaping the future of AI-assisted cell and gene therapy, and genome editing. We’re dedicated to integrating multimodal data, breaking down existing data silos, and crafting advanced machine learning models. These efforts aim to provide actionable insights, ultimately empowering gene therapy professionals to enhance patient outcomes.

Retain ownership of your data

Divergene’s platform offers a secure and readily accessible environment for the standardization, computation, and analysis of NGS data. This empowers the extraction of valuable insights from intricate sequencing datasets, with the potential to advance gene therapy and editing. We provide organizations with swift and comprehensive data analysis capabilities, enabling them to perform sequencing on their own samples, retain ownership of their samples and data, and leverage Divergene’s platform to derive actionable insights.

Our mission is to establish a pioneering technology company that significantly enhances patient outcomes through advanced NGS data analysis.

Our vision

At Divergene, we recognize that the convergence of molecular biology, data science, and computer science is the epicenter of groundbreaking advancements. Our paramount goal is to facilitate breakthrough therapies and elevate human well-being. We are actively dedicated to developing the requisite technologies to bring this vision to fruition.

Within the fabric of Divergene, we’ve cultivated a robust entrepreneurial ethos, igniting a passion within every team member to drive meaningful change. Our corporate DNA, built upon the pillars of quality, precision, and resilience, is the cornerstone of our success and a beacon of hope for millions, promising a brighter future.


Facts about Divergene
99 %
Positive feedback from customers and partners
< 60 days
To build, test and deploy new NGS analysis pipeline
> 8 x
More affordable than hiring an in-house team
> 10 x
Better customer service and response rate